Azam Safary

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 14

Top Venues

BioImpacts : BI

Infection

Expert opinion on biological therapy

Applied microbiology and biotechnology

Tabriz University of Medical Sciences

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Tabriz University of Medical Sciences Jun 23 2017

Iran

Assistant Professor :: Connective Tissue Diseases Research Center

Publications

Mostafa Akbarzadeh-Khiavi, Azam Safary, Yadollah Omidi
Targeting long non-coding RNAs as new modulators in anti-EGFR resistance mechanisms. BioImpacts : BI 14 (1) (2023)
Alireza Khabbazi, Maryam Mahmoudi, Kamal Esalatmanesh, Masoomeh Asgari-Sabet, Azam Safary
Vitamin D Status in Palindromic Rheumatism: A Propensity Score Matching Analysis. Laboratory medicine (2023)
Azam Safary, Mostafa Akbarzadeh-Khiavi, Morteza Mahmoudi, Yadollah Omidi
SARS-CoV-2 vaccine-triggered autoimmunity: Molecular mimicry and/or bystander activation of the immune system. BioImpacts : BI 13 (4) (2023)
Mostafa Akbarzadeh-Khiavi, Azam Safary, Yadollah Omidi
Targeting long non-coding RNAs as new modulators in anti-EGFR resistance mechanisms. BioImpacts : BI 14 (1) (2023)
Mostafa Akbarzadeh-Khiavi, Mitra Torabi, Amir-Hossein Olfati, Leila Rahbarnia, Azam Safary
Bio-nano scale modifications of melittin for improving therapeutic efficacy. Expert opinion on biological therapy 22 (7) (2022)
Shayan Simay, Mostafa Akbarzadeh-Khiavi, Mohammad M Pourseif, Jaleh Barar, Azam Safary, Yadollah Omidi
Recombinant production and characterization of L-glutaminase (glsA) as a promiscuity therapeutic enzyme. Applied microbiology and biotechnology 106 (17) (2022)
Mostafa Akbarzadeh-Khiavi, Mitra Torabi, Leila Rahbarnia, Azam Safary
Baricitinib combination therapy: a narrative review of repurposed Janus kinase inhibitor against severe SARS-CoV-2 infection. Infection 50 (2) (2021)
Fariba Lotfi, Mostafa Akbarzadeh-Khiavi, Ziba Lotfi, Leila Rahbarnia, Azam Safary, Habib Zarredar, Amir Baghbanzadeh, Behrooz Naghili, Behzad Baradaran
Micronutrient therapy and effective immune response: a promising approach for management of COVID-19. Infection 49 (6) (2021)
Azam Safary, Hakimeh Moghaddas Sani, Mostafa Akbarzadeh-Khiavi, Alireza Khabbazi, Mohammad A Rafi, Yadollah Omidi
Enzyme replacement combinational therapy: effective treatments for mucopolysaccharidoses. Expert opinion on biological therapy 21 (9) (2021)
Mostafa Akbarzadeh-Khiavi, Azam Safary, Morteza Mahmoudi, Hamed Farzi-Khajeh, Abolfazl Barzegari, Rahimeh Mousavi, Mohammad Hossein Somi, Yadollah Omidi
PEGylated gold nanoparticles-ribonuclease induced oxidative stress and apoptosis in colorectal cancer cells. BioImpacts : BI 10 (1) (2019)
Marziyeh Fathi, Azam Safary, Morteza Mahmoudi
Therapeutic impacts of enzyme-responsive smart nanobiosystems. BioImpacts : BI 10 (1) (2019)
Mostafa Akbarzadeh-Khiavi, Azam Safary, Mohammad Hossein Somi
Recent advances in targeted therapy of colorectal cancer: impacts of monoclonal antibodies nanoconjugates. BioImpacts : BI 9 (3) (2019)
Azam Safary, Mostafa Akbarzadeh-Khiavi, Rahimeh Mousavi, Morteza Mahmoudi, Mohammad A Rafi
Enzyme replacement therapies: what is the best option? BioImpacts : BI 8 (3) (2018)
Azam Safary, Rezvan Moniri, Maryam Hamzeh-Mivehroud, Siavoush Dastmalchi
Highly efficient novel recombinant L-asparaginase with no glutaminase activity from a new halo-thermotolerant Bacillus strain. BioImpacts : BI 9 (1) (2018)

Azam Safary.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Azam Safary